Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / DEA - DEA Vs. Biden FDA & Health Agency Over Cannabis Rescheduling: What's Up With That? | Benzinga


DEA - DEA Vs. Biden FDA & Health Agency Over Cannabis Rescheduling: What's Up With That? | Benzinga

Health and Human Services (HHS) Secretary Xavier Becerra hinted at potential reluctance within DEA circles regarding the Biden administration’s proposed rescheduling of marijuana.

At a recent event in Sacramento, Becerra addressed the status of moving cannabis to Schedule III of the Controlled Substances Act, indicating that his agency had acted based on scientific evidence and that the decision now rests with the Dept. of Justice.

When questioned about possible pushback from the DEA, Becerra evaded a direct response. In an interview with KQED’s Scott Schafer at the CalMatters Ideas Festival, Becerra sufficed with saying, “We did our job," then reiterated that the DEA has the final say in the matter.

Schafer pressed on, ...

Full story available on Benzinga.com

Stock Information

Company Name: Easterly Government Properties Inc.
Stock Symbol: DEA
Market: NYSE
Website: easterlyreit.com

Menu

DEA DEA Quote DEA Short DEA News DEA Articles DEA Message Board
Get DEA Alerts

News, Short Squeeze, Breakout and More Instantly...